RT Book, Section
A1 Albertson, Timothy E.
A2 Olson, Kent R.
A2 Anderson, Ilene B.
A2 Benowitz, Neal L.
A2 Blanc, Paul D.
A2 Clark, Richard F.
A2 Kearney, Thomas E.
A2 Kim-Katz, Susan Y.
A2 Wu, Alan H. B.
SR Print(0)
ID 1179990415
T1 AMPHETAMINES
T2 Poisoning & Drug Overdose, 7e
YR 2018
FD 2018
PB McGraw-Hill Education
PP New York, NY
SN 9780071839792
LK accessmedicine.mhmedical.com/content.aspx?aid=1179990415
RD 2024/04/19
AB Dextroamphetamine  (Dexedrine)  and  methylphenidate  (Ritalin)  are  used  for  the  treatment  of  narcolepsy  and  for  attention-deficit  disorders  in  children.  Methamphetamine  ("crank,"  "speed"),  3,4-methylenedioxymethamphetamine  (MDMA;  "ecstasy"),  paramethoxyamphetamine  (PMA),  and  several  other  amphetamine  derivatives,  as  well  as  a  number  of  prescription  drugs,  are  used  as  illicit  stimulants  and  hallucinogens  (see  also  "Lysergic  Acid  Diethylamide  [LSD]  and  Other  Hallucinogens").  "Ice"  is  a  high  purity,  smokable  crystalline  form  of  methamphetamine.  Methamphetamine  precursors  such  as  pseudoephedrine,  ephedrine,  and  other  over-the-counter  decongestants  are  discussed  on  Pseudoephedrine,  Phenylephrine,  and  other  Decongestants.  Several  amphetamine-related  drugs  (benzphetamine,  diethylpropion,  phendimetrazine,  phenmetrazine,  and  phentermine)  are  marketed  as  prescription  anorectic  medications  for  use  in  weight  reduction  (Table  II–1).  Fenfluramine  and  dexfenfluramine  were  marketed  as  anorectic  medications  but  were  withdrawn  from  the  market  in  1997  because  of  concerns  about  cardiopulmonary  toxicity  with  long-term  use.